CSF3 and Miyoshi myopathy: While various cyclophosphamide-based mobilization strategies are reported to mobilize SC while reducing toxicity [3] and improve SC yield, and prospective studies have used cyclophosphamide 1.0–7.0 g/m2 + G-CSF to mobilize SC in MM patients [2, 5–7], curative effects in MM have not been proven [8–10].